Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Polymyalgia Rheumatica
Email alerts
Polymyalgia Rheumatica
‘Slope sign’: a feature of large vessel vasculitis?
Bhaskar
Dasgupta
,
Kate
Smith
,
Abdullah Abu Syeed
Khan
,
Fiona
Coath
,
Richard J
Wakefield
Annals of the Rheumatic Diseases
Dec 2019,
78
(12)
1738;
DOI:
10.1136/annrheumdis-2019-216213
Checkpoint inhibitors and arthritis: seeking balance between victories and defeats
Carlos Antonio
Moura
,
Carlos Geraldo
Moura
Annals of the Rheumatic Diseases
Sep 2019,
78
(9)
e91;
DOI:
10.1136/annrheumdis-2018-213866
Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses
Christoph T
Berger
,
Birke
Rebholz-Chaves
,
Mike
Recher
,
Tobias
Manigold
,
Thomas
Daikeler
Annals of the Rheumatic Diseases
Jul 2019,
78
(7)
1012-1014;
DOI:
10.1136/annrheumdis-2018-214704
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor
Karmela Kim
Chan
,
Anne R
Bass
Annals of the Rheumatic Diseases
Jul 2019,
78
(7)
e70;
DOI:
10.1136/annrheumdis-2018-213672
Response to: ’Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass
Marie
Kostine
,
Léa
Dousset
,
Thierry
Schaeverbeke
Annals of the Rheumatic Diseases
Jul 2019,
78
(7)
e71;
DOI:
10.1136/annrheumdis-2018-213682
Incidence of inflammatory polyarthritis in polymyalgia rheumatica: a population-based cohort study
Max
Yates
,
Jalpa
Kotecha
,
Richard A
Watts
,
Robert
Luben
,
Kay-Tee
Khaw
,
Alexander J
MacGregor
Annals of the Rheumatic Diseases
May 2019,
78
(5)
704-705;
DOI:
10.1136/annrheumdis-2018-214386
Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study
Richard James
Partington
,
Sara
Muller
,
Toby
Helliwell
,
Christian D
Mallen
,
Alyshah
Abdul Sultan
Annals of the Rheumatic Diseases
Dec 2018,
77
(12)
1750-1756;
DOI:
10.1136/annrheumdis-2018-213883
Utility of PET/CT in the diagnosis of inflammatory rheumatic diseases: a systematic review and meta-analysis
Lucie
Descamps
,
Louis
Olagne
,
Charles
Merlin
,
Florent
Cachin
,
Martin
Soubrier
,
Sylvain
Mathieu
Annals of the Rheumatic Diseases
Nov 2018,
77
(11)
e81;
DOI:
10.1136/annrheumdis-2017-212660
Response to: ‘Is the PET/CT first choice for differential diagnosis of FUO/IUO?’ by Armagan
et al
Verena
Schönau
,
Georg
Schett
Annals of the Rheumatic Diseases
Nov 2018,
77
(11)
e83;
DOI:
10.1136/annrheumdis-2017-212785
Jacques FORESTIER, a visionary of the clinical epidemiology in rheumatology
Maxime
Dougados
Annals of the Rheumatic Diseases
Aug 2018,
77
(8)
1097-1098;
DOI:
10.1136/annrheumdis-2018-213560
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »
CLINICAL
Diagnostics
Clinical diagnostic tests
(1563)
Radiology (diagnostics)
(921)
Surgical diagnostic tests
(505)
Drugs and medicines
Endocrinology
Calcium and bone
(938)
Evidence based practice
Guidelines
(35)
Gastroenterology
Inflammatory bowel disease
(98)
Genetics
(1272)
Immunology (including allergy)
(6648)
Infectious diseases
Bone and joint infections
(93)
Travel medicine
(42)
Neurology
Muscle disease
(198)
Pain (neurology)
(1113)
Nutrition and metabolism
Obesity (nutrition)
(142)
Obstetrics and gynaecology
Menopause (including HRT)
(60)
Ophthalmology
(155)
Orthopaedics
Pathology
Inflammation
(1572)
Pathology
(531)
Pharmacology and therapeutics
Unwanted effects / adverse reactions
(15)
Pharmacology and therapeutics
Radiology
(1357)
Rehabilitation medicine
Disability
(32)
Other rehabilitative therapies
(18)
Physiotherapy
(52)
Renal medicine
(247)
Respiratory medicine
Interstitial lung disease
(181)
Pulmonary hypertension
(39)
Rheumatology
Ankylosing spondylitis
(567)
Biological agents
(731)
Connective tissue disease
(5506)
Degenerative joint disease
(6038)
Drugs: musculoskeletal and joint diseases
(916)
Fibromyalgia
(51)
Musculoskeletal syndromes
(6412)
Osteoarthritis
(1189)
Osteoporosis
(160)
Rheumatoid arthritis
(4213)
Sjogren's syndrome
(6)
Systemic lupus erythematosus
(724)
Vascularitis
(367)
Sports and exercise medicine
Physiotherapy
(33)
NON-CLINICAL
Epidemiology
(1862)
Health economics
(51)
Medical education
Postgraduate
(5)
Occupational and environmental medicine
(32)
Statistics and research methods
Special collections
ARD Lay summaries
(83)
Editor's choice
(161)
Guidelines, Recommendations and Consensus Statements
Open access
(1199)
Press releases
(50)
